PipelinePharma Logo
PipelinePharma Logo

CTD Dossier Marketplace

Direct connection with CTD dossier (IP) owners and manufacturers

Marketing Authorizations Database

Search across marketing authorization registers
Sign in Get started

Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-158 manufacturers

Filters

1 products found

pp-158

Concentrate for solution for infusion

Dossier type
CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Indication: NRG1 gene fusion-positive NSCLC; NRG1 fusion-positive pancreatic ductal adenocarcinoma Clinical stage: Phase 2 / BLA filed; FDA BLA under review Modality: Biologic (full-length IgG1 bispecific mAb — Biclonics platform) Mechanism / Target: HER2×HER3 bispecific — blocks NRG1 (heregulin) binding to HER3; prevents NRG1 fusion-driven HER2/HER3 heterodimerization and downstream PI3K/AKT activation Route / form: Intravenous infusion Differentiation: First bispecific antibody for NRG1 fusions; NRG1 fusions are rare genomic drivers (~0.2% NSCLC) with high unmet need; 36% ORR in NRG1+ NSCLC (eNRGy); biomarker-defined population
Manufacturer #15110

Clinical-stage oncology company developing bispecific antibodies using a proprietary Biclonics platform. Advances differentiated multi-target engaging biologics for gastrointestinal and other solid cancers. Wholly owned pipeline with Phase 3 bispecific mAb in head and neck cancer.
 

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.